Uncategorized

BioAxone receives fast track grant for Rho Kinase 2 inhibitor to improve outcomes in chronic SCI — SPINAL CORD INJURY RESEARCH AND ADVOCACY

CAMBRIDGE, Mass.–(BUSINESS WIRE)–BioAxone BioSciences, Inc. announced today the receipt of a Fast-Track grant (R44 NS110290-01) from the National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health, as part of the agency’s Small Business Innovation Research (SBIR) Program. The grant provides funding for milestone-driven research to assess the potential of […]

via BioAxone receives fast track grant for Rho Kinase 2 inhibitor to improve outcomes in chronic SCI — SPINAL CORD INJURY RESEARCH AND ADVOCACY

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s